Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × UNKNOWN × Endocrine × Clear all

Phase

Status

Sponsor Class

OTHER 256 INDUSTRY 64 NIH 54 NETWORK 6 OTHER_GOV 5 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 38 Breast 28 Thoracic 13 Head & Neck 10 Lymphoid 7 Gynecologic 3 CNS 3 Sarcoma 2 Genitourinary 2 Other solid neoplasm 1 Other neoplasm 1 NET 1 Endocrine 1

Conditions

Extrapancreatic Neuroendocrine Tumor 1

Interventions

Thalidomide 1 Temozolomide 1 Tegafur 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03204032 2017-06-29

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor

ChineseAMS

Phase 2 Unknown

EndocrineGastrointestinalNET

Extrapancreatic Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡